Panobinostat Lactate

CHEMBL3545368 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

439.5 g/mol

LogP

—

Phase

4

A lactate salt form of panobinostat with the same therapeutic properties. This cancer medication is used to treat multiple myeloma by blocking enzymes that help cancer cells survive and grow.

Moleküler Ağırlık

439,5000 g/mol

TPSA

135,00 Å²

Terapötik Alanlar

Melanoma

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(O)C(=O)O.Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1

InChI

InChI=1S/C21H23N3O2.C3H6O3/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26;1-2(4)3(5)6/h2-11,22-23,26H,12-14H2,1H3,(H,24,25);2,4H,1H3,(H,5,6)/b11-10+;

Molecular Formula

C24H29N3O5

HBD / HBA

6 / 6

Döndürülebilir Bağlar

8

Ağır Atomlar

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A lactate salt form of panobinostat with the same therapeutic properties. This cancer medication is used to treat multiple myeloma by blocking enzymes that help cancer cells survive and grow.

Yes, Panobinostat Lactate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3545368. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23725423. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Panobinostat Lactate PillFYI'da

Yapı

Hızlı Veriler

Formül: C24H29N3O5

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.